For help on how to get the results you want, see our search tips.
18 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Withdrawn applications Remove Withdrawn applications filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Exceptional circumstances Remove Exceptional circumstances filter
Additional monitoring Remove Additional monitoring filter
Biosimilar Remove Biosimilar filter
Generic Remove Generic filter
Opinion status
Positive Remove Positive filter
-
List item
Summary of opinion: Steglatro
ertugliflozin, opinion date: 16/09/2021, Positive, Last updated: 30/09/2021 -
List item
Summary of opinion: Segluromet
ertugliflozin, metformin hydrochloride, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Zepatier
elbasvir, grazoprevir, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Sapropterin Dipharma
sapropterin, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Lorviqua
lorlatinib, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Sitagliptin / Metformin hydrochloride Mylan
metformin hydrochloride, sitagliptin hydrochloride monohydrate, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Keytruda
pembrolizumab, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Lumykras
sotorasib, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Lonapegsomatropin Ascendis Pharma
lonapegsomatropin, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Wegovy
semaglutide, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Dupixent (new)
dupilumab, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Sondelbay (new)
teriparatide, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Dasatinib Accord (new)
dasatinib, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Dasatinib Accordpharma (new)
dasatinib, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Stimufend (new)
pegfilgrastim, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Vildagliptin / Metformin hydrochloride Accord (new)
vildagliptin / metformin hydrochloride, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Senshio (new)
ospemifene, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022